Association of decreased mean platelet volume with renal cell carcinoma

Zhi yuan Yun, Xin Zhang, Zhi ping Liu, Tiemin Liu, Rui tao Wang, Hui Chen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Renal cell carcinoma (RCC) is the third most common genitourinary cancer. Activated platelets play a pivotal role in cancer development and progression. Altered mean platelet volume (MPV) has been reported in several malignancies. The aim of the present study was to investigate the association of MPV with RCC. Study design: The study consisted of 145 patients with RCC, 110 patients with benign renal tumor and 132 healthy control subjects between January 2015 and December 2015. All participants’ clinical and laboratory characteristics at initial diagnosis were collected. The odds ratios (ORs) for RCC were calculated using multivariate logistic regression analysis after adjusting for confounding variables across MPV quartiles. Results: The patients with RCC had decreased pre-operative MPV compared to the patients with benign renal tumor and healthy control subjects. Furthermore, pre-operative MPV was reduced in benign renal tumor compared with healthy control subjects. Surgical tumor resection resulted in a significant increase in MPV levels (8.7 fL vs. 9.0 fL; p = 0.011). After adjusting for other risk factors, the ORs (95% CIs) for RCC in each MPV quartile were 25.725 (7.556–87.585), 7.447 (2.701–20.537), 0.703 (0.245–2.019), and 1.000, respectively. Conclusions: RCC patients have remarkably reduced MPV compared to patients with benign renal tumor and healthy control subjects. Moreover, decreased MPV was independently associated with RCC. Our results suggest that detection of MPV may be useful to assess the risk of RCC.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalInternational Journal of Clinical Oncology
DOIs
StateAccepted/In press - Jun 29 2017

Fingerprint

Mean Platelet Volume
Renal Cell Carcinoma
Healthy Volunteers
Neoplasms
Kidney
Odds Ratio
Urogenital Neoplasms
Confounding Factors (Epidemiology)
Blood Platelets
Logistic Models
Regression Analysis

Keywords

  • Diagnosis
  • Mean platelet volume
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Cite this

Association of decreased mean platelet volume with renal cell carcinoma. / Yun, Zhi yuan; Zhang, Xin; Liu, Zhi ping; Liu, Tiemin; Wang, Rui tao; Chen, Hui.

In: International Journal of Clinical Oncology, 29.06.2017, p. 1-5.

Research output: Contribution to journalArticle

Yun, Zhi yuan ; Zhang, Xin ; Liu, Zhi ping ; Liu, Tiemin ; Wang, Rui tao ; Chen, Hui. / Association of decreased mean platelet volume with renal cell carcinoma. In: International Journal of Clinical Oncology. 2017 ; pp. 1-5.
@article{5338cff051364a54bcd5f2054e824e85,
title = "Association of decreased mean platelet volume with renal cell carcinoma",
abstract = "Background: Renal cell carcinoma (RCC) is the third most common genitourinary cancer. Activated platelets play a pivotal role in cancer development and progression. Altered mean platelet volume (MPV) has been reported in several malignancies. The aim of the present study was to investigate the association of MPV with RCC. Study design: The study consisted of 145 patients with RCC, 110 patients with benign renal tumor and 132 healthy control subjects between January 2015 and December 2015. All participants’ clinical and laboratory characteristics at initial diagnosis were collected. The odds ratios (ORs) for RCC were calculated using multivariate logistic regression analysis after adjusting for confounding variables across MPV quartiles. Results: The patients with RCC had decreased pre-operative MPV compared to the patients with benign renal tumor and healthy control subjects. Furthermore, pre-operative MPV was reduced in benign renal tumor compared with healthy control subjects. Surgical tumor resection resulted in a significant increase in MPV levels (8.7 fL vs. 9.0 fL; p = 0.011). After adjusting for other risk factors, the ORs (95{\%} CIs) for RCC in each MPV quartile were 25.725 (7.556–87.585), 7.447 (2.701–20.537), 0.703 (0.245–2.019), and 1.000, respectively. Conclusions: RCC patients have remarkably reduced MPV compared to patients with benign renal tumor and healthy control subjects. Moreover, decreased MPV was independently associated with RCC. Our results suggest that detection of MPV may be useful to assess the risk of RCC.",
keywords = "Diagnosis, Mean platelet volume, Renal cell carcinoma",
author = "Yun, {Zhi yuan} and Xin Zhang and Liu, {Zhi ping} and Tiemin Liu and Wang, {Rui tao} and Hui Chen",
year = "2017",
month = "6",
day = "29",
doi = "10.1007/s10147-017-1158-2",
language = "English (US)",
pages = "1--5",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Association of decreased mean platelet volume with renal cell carcinoma

AU - Yun, Zhi yuan

AU - Zhang, Xin

AU - Liu, Zhi ping

AU - Liu, Tiemin

AU - Wang, Rui tao

AU - Chen, Hui

PY - 2017/6/29

Y1 - 2017/6/29

N2 - Background: Renal cell carcinoma (RCC) is the third most common genitourinary cancer. Activated platelets play a pivotal role in cancer development and progression. Altered mean platelet volume (MPV) has been reported in several malignancies. The aim of the present study was to investigate the association of MPV with RCC. Study design: The study consisted of 145 patients with RCC, 110 patients with benign renal tumor and 132 healthy control subjects between January 2015 and December 2015. All participants’ clinical and laboratory characteristics at initial diagnosis were collected. The odds ratios (ORs) for RCC were calculated using multivariate logistic regression analysis after adjusting for confounding variables across MPV quartiles. Results: The patients with RCC had decreased pre-operative MPV compared to the patients with benign renal tumor and healthy control subjects. Furthermore, pre-operative MPV was reduced in benign renal tumor compared with healthy control subjects. Surgical tumor resection resulted in a significant increase in MPV levels (8.7 fL vs. 9.0 fL; p = 0.011). After adjusting for other risk factors, the ORs (95% CIs) for RCC in each MPV quartile were 25.725 (7.556–87.585), 7.447 (2.701–20.537), 0.703 (0.245–2.019), and 1.000, respectively. Conclusions: RCC patients have remarkably reduced MPV compared to patients with benign renal tumor and healthy control subjects. Moreover, decreased MPV was independently associated with RCC. Our results suggest that detection of MPV may be useful to assess the risk of RCC.

AB - Background: Renal cell carcinoma (RCC) is the third most common genitourinary cancer. Activated platelets play a pivotal role in cancer development and progression. Altered mean platelet volume (MPV) has been reported in several malignancies. The aim of the present study was to investigate the association of MPV with RCC. Study design: The study consisted of 145 patients with RCC, 110 patients with benign renal tumor and 132 healthy control subjects between January 2015 and December 2015. All participants’ clinical and laboratory characteristics at initial diagnosis were collected. The odds ratios (ORs) for RCC were calculated using multivariate logistic regression analysis after adjusting for confounding variables across MPV quartiles. Results: The patients with RCC had decreased pre-operative MPV compared to the patients with benign renal tumor and healthy control subjects. Furthermore, pre-operative MPV was reduced in benign renal tumor compared with healthy control subjects. Surgical tumor resection resulted in a significant increase in MPV levels (8.7 fL vs. 9.0 fL; p = 0.011). After adjusting for other risk factors, the ORs (95% CIs) for RCC in each MPV quartile were 25.725 (7.556–87.585), 7.447 (2.701–20.537), 0.703 (0.245–2.019), and 1.000, respectively. Conclusions: RCC patients have remarkably reduced MPV compared to patients with benign renal tumor and healthy control subjects. Moreover, decreased MPV was independently associated with RCC. Our results suggest that detection of MPV may be useful to assess the risk of RCC.

KW - Diagnosis

KW - Mean platelet volume

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85021773389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021773389&partnerID=8YFLogxK

U2 - 10.1007/s10147-017-1158-2

DO - 10.1007/s10147-017-1158-2

M3 - Article

C2 - 28664301

AN - SCOPUS:85021773389

SP - 1

EP - 5

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

ER -